Charlotte CFS/ME/FM Support Group Newsletter

for July 1, 2010

 

 

Dear Members,

 

As I listed in my last several newsletters, during July and August, instead of Thursday night meetings (3rd Thursday of the month), we'll have luncheons at 1:30PM the afternoon of that day instead.  This is a great opportunity to have some casual time to get to know one another better. I'll send out a reminder just before the July 15th luncheon.

 

July 15th;       1:30PM, at Souper Salad,  10046 E. Independence Blvd, Charlotte

August 19th; 1:30PM, at Panera Bread, 7510 Pineville Matthews Rd. Charlotte

 

No regular meetings on the 3rd Thursday of the month during July and August. 

Regular meetings will resume September 16th.

 

*****************************************************************************************

The first article is long so I'd advise to first skim thru to look for articles that interest you the most before you attempt to read the long one. I personally print long articles out to read later.

 

******************************************************************************************

 

 

BREAKING NEWS:

Original Press Release from the Netherlands: FDA and NIH confirm 'XMRV findings'

Gendringen, NL (MMD Newswire) June 22, 2010 -- The FDA and the NIH have independently confirmed the XMRV findings as published in Science, October last. This confirmation was issued by Dr. Harvey Alter of the NIH during a closed workshop on blood transfusion held on May 26-27 in Zagreb. Two journalists from the Dutch magazine for health professionals, ORTHO, who have been working on XMRV stories for several months, were able to obtain a copy of the Alter lecture.

In the October 8, 2009 issue of Science Express, the Lombardi-Mikovits group at the Whittemore Peterson Institute (WPI), the Cleveland Clinic and the National Cancer Institute (NCI) reported that 67% of 101 chronic fatigue syndrome (CFS) patients tested positive for infection with xenotropic murine retrovirus (XMRV). Only 3.7% of 218 healthy subjects tested were positive for this gammaretrovirus. Since that time, a number of research groups have proved unable to independently confirm these findings.

On Friday last, the AABB released an Association Bulletin recommending that its member blood collectors actively discourage potential donors who have been diagnosed with CFS from donating blood or blood components. This interim measure was proposed by the AABB Interorganizational Task Force on XMRV. This Task Force includes representatives from several government agencies, including the Center for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the National Institutes of Health (NIH).

The fact that the measure was introduced suggests the presence of information not yet published. The ORTHO journalists were able to obtain a pdf document of the lecture given by Harvey Alter at the IPFA/PEI 17th Workshop on 'Surveillance and screening of Blood Borne Pathogens' in Zagreb. The International Plasma Fractionation Association (IPFA) represents the not-for-profit organizations around the world involved in plasma fractionation. The IPFA is based in Amsterdam, the Netherlands.

The highly-experienced Dr. Harvey Alter is Clinical Studies Chief at the Infectious Diseases and Immunogenetics Section of the Department of Transfusion Medicine at the NIH Clinical Center in Bethesda. "The data in the Lombardi, et al Science manuscript are extremely strong and likely true, despite the controversy", was one comment on the XMRV findings reported by Alter in Zagreb. "Although blood transmission to humans has not been proved, it is probable. The association with CFS is very strong, but causality not proved. XMRV and related MLVs are in the donor supply with an early prevalence estimate of 3%7%. We (FDA & NIH) have independently confirmed the Lombardi group findings."

ORTHO contacted Dr. Harvey Alter today for a reaction. He did not want to comment, but confirmed that a paper is soon to be published.

ORTHO is a Dutch magazine for health professionals focusing on nutrition and dietary supplements. ORTHO has been publishing reports on CFS since 1988. Editor-in-chief: Gert E. Schuitemaker (PhD). Tel: + 31 (0) 315 695211 / + 49 (0) 170 808 9484. E-mail: ortho@orthoeurope.com.

Paper soon to be released.  June 22, 2010

“We (FDA & NIH) have independently confirmed the Lombardi group findings." -  Dr. Harvey Alter, National Institutes of Health

Gendringen, the Netherlands, Jun 22 - The FDA and the NIH have independently confirmed the XMRV findings as published in Science, October last.

This confirmation was issued by Dr. Harvey Alter of the NIH during a closed workshop on blood transfusion held on May 26-27 in Zagreb.

Two journalists from the Dutch magazine for health professionals, ORTHO, who have been working on XMRV stories for several months, were able to obtain a copy of the Alter lecture.

In the October 8, 2009 issue of Science Express, the Lombardi-Mikovits group at the Whittemore Peterson Institute (WPI), the Cleveland Clinic, and the National Cancer Institute (NCI) reported that 67% of 101 chronic fatigue syndrome (CFS) patients tested positive for infection with xenotropic murine retrovirus (XMRV). Only 3.7% of 218 healthy subjects tested were positive for this gammaretrovirus.

Since that time, a number of research groups have proved unable to independently confirm these findings.

On Friday last (June 18, 2010), the AABB [formerly American Association of Blood Banks, now with members in 80 countries] released an Association Bulletin recommending that its member blood collectors actively discourage potential donors who have been diagnosed with CFS from donating blood or blood components.

This interim measure was proposed by the AABB Interorganizational Task Force on XMRV. This Task Force includes representatives from several government agencies, including the Center for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). The fact that the measure was introduced suggests the presence of information not yet published.

The ORTHO journalists were able to obtain a pdf document of the lecture given by Harvey Alter at the IPFA/PEI 17th Workshop on 'Surveillance and Screening of Blood Borne Pathogens” in Zagreb. The International Plasma Fractionation Association (IPFA) represents the not-for-profit organizations around the world involved in plasma fractionation. The IPFA is based in Amsterdam, the Netherlands.

The highly-experienced Dr. Harvey Alter is Clinical Studies Chief at the Infectious Diseases and Immunogenetics Section of the Department of Transfusion Medicine at the NIH Clinical Center in Bethesda, Maryland.

• "The data in the Lombardi, et al. Science manuscript are extremely strong and likely true, despite the controversy," was one comment on the XMRV findings reported by Alter in Zagreb.

• "Although blood transmission to humans has not been proved, it is probable.

• "The association with CFS is very strong, but causality not proved.

• "XMRV and related MLVs are in the donor supply with an early prevalence estimate of 3% to 7%."

• "We (FDA & NIH) have independently confirmed the Lombardi group findings."


ORTHO contacted Dr. Harvey Alter today for a reaction. He did not want to comment, but confirmed that a paper is soon to be published.

[Ed Note: See also Hillary Johnson's blog (
"THE BIG ONE, June 21, 2010") stating she's learned by the grapevine that an article now in press at "a highly respected journal" may provide new, "even stronger" data connecting XMRV with ME/CFS than the Mikovits article. Hillary wrote the notable book, Osler's Web.]

Source: ORTHO news release, June 22, 2010. ORTHO is a Dutch magazine for health professionals focusing on nutrition and dietary supplements, based in Gendringen, the Netherlands. ORTHO has been publishing reports on CFS since 1988. Editor-in-chief: Gert E. Schuitemaker (PhD). Tel: + 31 (0) 315 695211 + 31 (0) 315 695211 / + 49 (0) 170 808 9484 + 49 (0) 170 808 9484. E-mail:
ortho@orthoeurope.com

 

There are a variety of sources for this info on XMRV, this is from Hillary Johnson's blog.  

 

 Date:    Tue, 22 Jun 2010 19:34:55 -0400
From:    Hillary Johnson via Co-Cure Moderator <ray@co-cure.org>
Subject: RES: Lombardi et al to be confirmed

I've published a brief notice about a study soon to be published in a prestigious scientific journal by FDA and NIH scientists that abundantly confirms the Lombardi et. al. Science paper of last October.

The story is on my first page, and on my update page

http://www.OslersWeb.com

and: 

http://www.oslersweb.com/blog.htm?


Thanks, Hillary Johnson

 (NOTE:  Hillary Johnson is the author of the very important book "Osler's Web" - a book that tells the story of how CFS was negligently treated in the early years. For you history buffs, this will be both sad and fascinating how our government does and DOESN'T work.)


Hillary now offers her latest findings via her blog as noted above.    

 

 

Reminders from Dr. Lapp:

Calling For Patients:  Ampligen Study Is Still Recruiting

Hunter-Hopkins Center is one of two sites in the USA currently participating in an open label study of Ampligen. Persons with CFS may qualify to receive Ampligen therapy. Details are available on the US government Clinical Trials website at: http://www.clinicaltrials.gov/ct2/show/NCT00215813?term=00215813&rank=1

The Hunter-Hopkins program is described at http://www.drlapp.net/ampligen.htm  

If you are interested in joining the Ampligen Study or you have more questions, contact Wendy Fallick (Research Coordinator) or Dr. Black at Hunter-Hopkins.

Also:

Dr. Lapp's Web Site:  www.drlapp.net

Dr. Lapp's Treatment Site:     http://www.cfstreatment.info/

 

 

 

New Fibromyalgia Diagnostic Criteria Proposed

 http://www.healthcentral.com/utils/newsweb/chronic-pain/news-sp.html

 

 

The Whittemore-Peterson Institute

How this institute came to be, read this snippet by Annette Whittemore:

 

 "...Perhaps what is missing most from the public’s awareness is the description of the most severely ill patients, like Andrea, who, at times, was so ill and weak that she was unable to feed herself or walk unaided. As these patients’ immune systems weaken and various chronic infections take hold, they live their lives between doctor’s offices and their homes physically and emotionally isolated from their families, friends, and communities. Many go on to develop life-threatening complications. In a retrospective analysis, Leonard Jason found that those diagnosed with ME/CFS died of heart disease, cancer, or suicide at ages approximately twenty-five years younger than the normal population (3). Only detailed epidemiological studies will reveal the true complications of long term disease and mortality resulting from the complications of this disease.

The problems that patients experience when dealing with the healthcare system can be as difficult as the disease itself. Most doctors have difficulty diagnosing ME/CFS and when they do, are at a loss as to what to do for their patients. The lack of medical consensus is so great that most doctors disagree on the best treatment strategies or what, if any, biological treatments to consider. Doctors and patients are left to their own devices, experimenting with drug treatments that are unproven, toxic, or both. Scientific and educational information surrounding ME/CFS is conflicting and often consists of anecdotal observations from physicians. Additionally, many patients are told they suffer from “faulty thinking” about the illness and are then prescribed cognitive behavioral therapy and graded exercise therapy."...

 

The New Jersey Consensus Manual for Primary Care and Management of CFS

This is a PDF file but go to page iii to look thru the Table of Contents, then you can scroll to a particular page of interest.

http://njcfsa.org/Manual.pdf

 

E-Newsletters from Adrienne Delwo - Guide at About.com ME/CFS & FM Forum

http://specials.abo-ut.com/service/newsletters/chronicfatigue/1277492400.htm

 

 

June 26, 2010 /24-7PressRelease/ -- Establishing "Disability"For Claimants With Fibromyalgia and Chronic Fatigue Syndrome


This is an overview of the process that I hope you will find helpful.  Many of you already are receiving benefits while some are still "thinking" about it.

 

http://www.24-7pressrelease.com/press-release/social-security-disability-and-fibromyalgia-158003.php

 

Machine to Clean Viruses from the Blood

I found this intriguing not just because of the stronger and stronger possibility of the XMRV retrovirus being associated with CFS but for all disease tiggered or caused by a virus. I have no idea how valid this is but definitely interesting.

http://www.sciencedaily.com/videos/2008/0602-cleaning_infected_blood.htm

Dangers of Fluoroquinolones - Cipro and Some Other Antibiotics Can Cause Severe Adverse Reactions

This was passed along to me to share some time ago. Its not new news, but worth repeating.

 

http://chronicillness.suite101.com/article.cfm/dangers_of_fluoroquinolones

 

 

 

Pain characteristics of people with chronic fatigue syndrome

http://www.meresearch.org.uk/research/projects/pain.html

 


 

Click for Free Donations to Animals, Breast Cancer, Hunger, etc.

Many of you already do this, but I want to let others know how they can sign up for a daily reminder to click on these sites to get free donations to various charities.  Its so easy, once you sign up, you just click on each to bring up the page and then click on a colored large button, then move on to the next tab at the top. There are about half a dozen charities you can help.

http://greatergood.com/emails/2010/reminder-062310-ARS-w.html

 

 

 

Your Smile for Today

 

http://purinaanimalallstars.yahoo.com/?v=7652402&l=100000085

 

Nancy Henson